Status:
COMPLETED
Development and Evaluation of Virtual Reality Experiences for Cognitive Stimulation at the Sociosanitary Center El Carme
Lead Sponsor:
Badalona Serveis Assistencials
Collaborating Sponsors:
Public Health Agency of Barcelona
Reality Telling SL
Conditions:
Cognitive Dysfunction
Mild Cognitive Impairment
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test a virtual reality (VR)-based program designed for cognitive stimulation in individuals attending the conventional cognitive rehabilitation program at the Day...
Detailed Description
Background: Cognitive impairment affects a significant portion of the aging population, leading to challenges in daily functioning and a reduced quality of life. Traditional cognitive rehabilitation ...
Eligibility Criteria
Inclusion
- Participants must be classified as having mild cognitive impairment with a Mini-Mental State Examination (MMSE) score greater than 23.
- Participants must be currently attending cognitive rehabilitation sessions at the Day Hospital of the Centro Sociosanitario El Carme (CSSC).
- Participants must be able to give informed consent or, in the case of incapacity, consent must be obtained from their legal representative.
Exclusion
- Patients with a severe or unstable illness that could interfere with participation in the study.
- Patients with serious psychiatric disorders, such as psychotic disorders, delusions, or hallucinations that may be exacerbated by the use of virtual reality.
- Patients with severe visual limitations that would prevent the use of virtual reality.
- Presence of ocular diseases causing blurred vision that cannot be corrected with contact lenses or glasses.
- Presence of auditory pathologies that cause a significant decrease in hearing without hearing aids.
- High sensitivity to motion sickness.
- Subjects with epilepsy.
- Patients who are unable or unwilling to give informed consent.
- Withdrawal Criteria
- The emergence of health problems that could interfere with the continuity of participation in the study, or the withdrawal of consent by the participant.
Key Trial Info
Start Date :
October 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 27 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06155721
Start Date
October 30 2023
End Date
March 27 2024
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Socio Sanitario El Carmen
Badalona, Barcelona, Spain, 08917